Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
| PURINETHOL | 50MG | TABLET | Resolved | 2024-07-03 | 2025-12-06 | 231946 |
| RATIO-AMCINONIDE | 0.1% | LOTION | Actual shortage | 2017-05-23 | 2017-10-05 | 10880 |
| RATIO-AMCINONIDE | 0.1% | OINTMENT | Actual shortage | 2017-08-01 | 2018-12-21 | 17796 |
| RATIO-AMCINONIDE | 0.1% | CREAM | Actual shortage | 2017-08-01 | 2018-12-21 | 17799 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1790 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
| RATIO-ATORVASTATIN | 40MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-10 | 1803 |
| RATIO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2017-03-14 | 2018-12-21 | 2343 |
| RATIO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2017-05-23 | 2017-10-05 | 10883 |
| TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2359 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-10 | 2017-11-07 | 167 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-14 | 2017-11-06 | 2370 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2017-09-21 | 2017-11-06 | 22942 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-03-12 | 2020-04-23 | 108604 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-02-21 | 2374 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-03-08 | 2380 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2017-09-21 | 2018-03-07 | 22945 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |